Drug Type Diagnostic radiopharmaceuticals |
Synonyms 89Zr-Df IAB41M2C |
Target |
Action modulators |
Mechanism CD4 modulators(T-cell surface antigen CD4 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Preclinical | United States | 01 Apr 2026 | |
| Neoplasms | Preclinical | United States | 01 Apr 2026 |





